BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 18042478)

  • 1. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Skurtveit S; Furu K; Kaasa S; Borchgrevink PC
    Eur J Pain; 2009 Oct; 13(9):949-53. PubMed ID: 19095476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data.
    Parente ST; Kim SS; Finch MD; Schloff LA; Rector TS; Seifeldin R; Haddox JD
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):783-90. PubMed ID: 15623267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescription shopping of addictive drugs in Norway].
    Winther RB; Bramness JG
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):517-20. PubMed ID: 19282887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid use by patients in an orthopedics spine clinic.
    Mahowald ML; Singh JA; Majeski P
    Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.
    Shireman TI; Rigler SK
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):210-8. PubMed ID: 17062321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.
    Bramness JG; Furu K; Skurtveit S; Engeland A
    Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between pharmacy closures and prescription drug use: a retrospective analysis of Medicaid prescription claims in Iowa.
    Xiao H; Sorofman B; Manasse HR
    Am J Manag Care; 2000 Mar; 6(3):366-72. PubMed ID: 10977436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.
    Fredheim OM; Skurtveit S; Moroz A; Breivik H; Borchgrevink PC
    Acta Anaesthesiol Scand; 2009 May; 53(5):627-33. PubMed ID: 19419357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
    Toth PP; Urtis J
    Clin Ther; 2004 Sep; 26(9):1355-67. PubMed ID: 15530999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment due to intake of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J
    Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C; Barner JC; Lawson KA; Johnsrud MT
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
    Bramness JG; Furu K; Engeland A; Skurtveit S
    Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of Medicaid and pharmacy record data in inner-city children with asthma.
    Mudd KE; Bollinger ME; Hsu VD; Manning A; Tsoukleris MG; Butz AM
    Contemp Clin Trials; 2008 Jan; 29(1):13-20. PubMed ID: 17574930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carisoprodol legal status and patterns of abuse.
    Fass JA
    Ann Pharmacother; 2010 Dec; 44(12):1962-7. PubMed ID: 21062909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abuse of Carisoprodol].
    Lindberg N; Lauerma H
    Duodecim; 1996; 112(2):109-11. PubMed ID: 10590614
    [No Abstract]   [Full Text] [Related]  

  • 20. Analytic models to identify patients at risk for prescription opioid abuse.
    White AG; Birnbaum HG; Schiller M; Tang J; Katz NP
    Am J Manag Care; 2009 Dec; 15(12):897-906. PubMed ID: 20001171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.